Entasis Therapeutics Holdings Inc.
USD2.19
-0.01 (-0.45%)
CEO
Manoussos Perros
IPO Date
2018-09-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.19
Prev. Close
$2.20
Day Low
$2.19
Day High
$2.20
| 150,000 |
| $0.00 |
| 11 Jul 2022 | Altarac David | Chief Medical Officer | J-Other | Disposed | 92,307 | $2.44 |
| 11 Jul 2022 | Altarac David | Chief Medical Officer | U-Tender | Disposed | 17,572 | $2.20 |
| 11 Jul 2022 | Mayer Howard | director | J-Other | Disposed | 12,500 | $2.44 |
| 11 Jul 2022 | Mayer Howard | director | U-Tender | Disposed | 22,000 | $2.20 |
| 11 Jul 2022 | Mayer Howard | director | D-Return | Disposed | 27,500 | $2.20 |
| 11 Jul 2022 | Mayer Howard | director | J-Other | Disposed | 11,000 | $2.98 |
| 11 Jul 2022 | Meek David D. | director | U-Tender | Disposed | 22,000 | $2.20 |
| 11 Jul 2022 | Meek David D. | director | D-Return | Disposed | 27,500 | $2.20 |